Chemical Compound

L-Lysine, L-alpha-aspartyl-L-alpha-glutamyl-L-leucyl-L-phenylalanyl-L-seryl-L-tyrosyl-L-leucyl-L-isoleucyl-L-alpha-glutamyl-L-lysyl-L-valyl-L-lysyl-L-arginyl-L-lysyl-

CAS Registry Number 2749522-60-7
L-Lysine, L-alpha-aspartyl-L-alpha-glutamyl-L-leucyl-L-phenylalanyl-L-seryl-L-tyrosyl-L-leucyl-L-isoleucyl-L-alpha-glutamyl-L-lysyl-L-valyl-L-lysyl-L-arginyl-L-lysyl- 结构式
Primary record

L-Lysine, L-alpha-aspartyl-L-alpha-glutamyl-L-leucyl-L-phenylalanyl-L-seryl-L-tyrosyl-L-leucyl-L-isoleucyl-L-alpha-glutamyl-L-lysyl-L-valyl-L-lysyl-L-arginyl-L-lysyl-

库存
5,937 克
纯度
99.5 %
CAS
2749522-60-7

化合物标识与属性

CAS
2749522-60-7
PubChem CID
164512925
SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C

名称与同义词

  • UNII-A6VUD4WYT9
  • A6VUD4WYT9
  • Prame (189-203)
  • Pepmix-human (prame/oip4) component prame (189-203)
  • Asp-Glu-Leu-Phe-Ser-Tyr-Leu-Ile-Glu-Lys-Val-Lys-Arg-Lys-Lys
  • Melanoma antigen preferentially expressed in tumors (189-203)
  • 2749522-60-7
  • L-Lysine, L-alpha-aspartyl-L-alpha-glutamyl-L-leucyl-L-phenylalanyl-L-seryl-L-tyrosyl-L-leucyl-L-isoleucyl-L-alpha-glutamyl-L-lysyl-L-valyl-L-lysyl-L-arginyl-L-lysyl-